XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.25.3

Liability Related to Sale of Future Royalties (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Liability Related to Sale of Future Royalties [Abstract] |
Liability Related to Sale of Future Royalties | The following table sets forth information on our liability related to sale of future royalties (in thousands):
Liability related to sale of future royalties, net as of December 31, 2024 | $ | 542,212 |
Royalty payments to Royalty Pharma |  | (38,478 | )
Interest expense related to sale of future royalties |  | 54,964 |
Amortization of issuance costs related to sale of future royalties |  | 458 |
Liability related to sale of future royalties, net as of September 30, 2025 | $ | 559,156 |
Less: Current portion (1) |  | (13,974 | )
Liability related to sale of future royalties, net as of September 30, 2025 – Non-current | $ | 545,182 |

X
- References No definition available. + Details
Name: | us-gaap_OtherLiabilitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of other noncurrent liabilities. + References No definition available. + Details
Name: | us-gaap_OtherNoncurrentLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration